Gsk

Cipla submits application with USFDA for generic version of asthma drug

Drug major Cipla on Monday said it has submitted an application with the US health regulator for a generic version of GSK's Advair Diskus, which is used in the treatment of asthma and other respiratory disorders

Sensex plunges over 800 points, Nifty slumps 227 points in early trade as economic package fails to impress

After hitting a low of 30,265.67, the Sensex was trading 731.91 points or 2.35 percent lower at 30,365.82. Similarly, NSE Nifty slumped 226.90 points, or 2.48 percent, to 8,909.95.

GSK exits HUL, offloads 5.7% stake for Rs 25,480 cr in largest block trade ever carried out in Indian equity market

On 1 April 2020, GSK had announced the completion of its divestment of its popular healthcare drink brand Horlicks and other consumer healthcare nutrition products in India to Unilever.

CCI approves GlaxoSmithKline, Pfizer consumer healthcare joint venture

The Competition Commission on Friday said it has approved the formation of a joint venture for consumer healthcare products by pharmaceutical giants GlaxoSmithKline (GSK) and Pfizer

Pfizer to shut down two plants in India citing unviability; decision leaves about 1,700 employees in lurch

Pfizer will soon shut down its plants in Aurangabad, Maharashtra and Irungattukottai (IKKT) near Chennai in Tamil Nadu citing lack of viability.

GSK and Pfizer to combine consumer health businesses; British drugmaker plans to split into two businesses

GSK said the deal laid the foundation for the creation of two new UK-based global companies focused on pharmaceuticals/vaccines and consumer healthcare

Energy shot for HUL: Will buyout of GSK's Horlicks, Boost brands work wonders for the consumer giant?

At first glance, this deal looks expensive from the point of view of HUL, but the acquisition of Boost, Viva and Maltova would significantly boost its foods and refreshment business, going forward.

GSK Consumer Healthcare says it is considering potential transaction of nutrition business; Unilever confirms development

Hindustan Unilever, the Indian arm of Unilever, confirmed that the company was in the race to acquire GlaxoSmithKline Plc's consumer healthcare nutrition products

Study of genes uncovers secrets of parasitic worms and new ways to treat infections

The study offers the best insight yet into parasite biology & how they evade our immune systems.

Coca-Cola in race to buy Horlicks from GlaxoSmithKline, value of transaction could be around $3.9 billion

Besides Coca-Cola, several global FMCG makers as Nestle, Kraft Heinz are in the race to acquire Horlicks from GSK